Update information
August 2016: This guidance was re-issued after a change to the commercial arrangements in August 2016. This change did not affect cost effectiveness. The following sections of the guidance have been updated: recommendation 1.1; sections 2.3, 3.20, 3.34, 3.36, 4.19, 4.21, 4.32 and 5.4; and the table summarising the appraisal committee's key conclusions.
Minor changes since publication
November 2021: Guidance updated because the commercial arrangement has changed to a simple discount patient access scheme alone.
ISBN: 978-1-4731-1881-2